---
$id: https://graph.org.ai/products/commodity/51343812
$type: Product
source: UNSPSC
code: "51343812"
title: "Dolutegravir/emitricitabine/tenofovir alafenamide"
class: "51343800"
classTitle: "Combination antivirals"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dolutegravir/emitricitabine/tenofovir alafenamide

**UNSPSC Code**: 51343812
**Class**: [Combination antivirals](Combination antivirals.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug for treatment of HIV. The first component, DOLUTEGRAVIR, has US FDA Unique Ingredient Identifier of DKO1W9H7M1. The second component, EMTRICITABINE, has US FDA Unique Ingredient Identifier of G70B4ETF4S. The third component, TENOFOVIR ALAFENAMIDE, has US FDA Unique Ingredient Identifier of EL9943AG5J.

